BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17629526)

  • 1. The effects of prednisone on haemostasis in leishmaniotic dogs treated with meglumine antimoniate and allopurinol.
    Cortese L; Pelagalli A; Piantedosi D; Mastellone V; Di Loria A; Lombardi P; Ciaramella P; Avallone L
    Vet J; 2008 Sep; 177(3):405-10. PubMed ID: 17629526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic fibropoiesis in dogs naturally infected with Leishmania (Leishmania) infantum treated with liposome-encapsulated meglumine antimoniate and allopurinol.
    Castro RS; de Amorim IFG; Pereira RA; Silva SM; Pinheiro LJ; Pinto AJW; Azevedo EG; Demicheli C; Caliari MMV; Mosser DM; Michalick MSM; Frezard FJG; Tafuri WL
    Vet Parasitol; 2018 Jan; 250():22-29. PubMed ID: 29329619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid function in 36 dogs with leishmaniosis due to Leishmania infantum before and during treatment with allopurinol with or without meglumine antimonate.
    Saridomichelakis MN; Xenoulis PG; Chatzis MK; Kasabalis D; Steiner JM; Suchodolski JS; Petanides T
    Vet Parasitol; 2013 Oct; 197(1-2):22-8. PubMed ID: 23685064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical follow-up examination after treatment of canine leishmaniasis.
    Moritz A; Steuber S; Greiner M
    Tokai J Exp Clin Med; 1998 Dec; 23(6):279-83. PubMed ID: 10622623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-time PCR assay in Leishmania-infected dogs treated with meglumine antimoniate and allopurinol.
    Manna L; Reale S; Vitale F; Picillo E; Pavone LM; Gravino AE
    Vet J; 2008 Aug; 177(2):279-82. PubMed ID: 17553711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PCR follow-up examination after treatment of canine leishmaniosis (CaL).
    Steuber S; Moritz A; Schirrmann I; Greiner M
    Tokai J Exp Clin Med; 1998 Dec; 23(6):285-92. PubMed ID: 10622624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term follow-up of dogs diagnosed with leishmaniosis (clinical stage II) and treated with meglumine antimoniate and allopurinol.
    Torres M; Bardagí M; Roura X; Zanna G; Ravera I; Ferrer L
    Vet J; 2011 Jun; 188(3):346-51. PubMed ID: 20594876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol.
    Manna L; Corso R; Galiero G; Cerrone A; Muzj P; Gravino AE
    Parasit Vectors; 2015 May; 8():289. PubMed ID: 26017164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
    Vouldoukis I; Rougier S; Dugas B; Pino P; Mazier D; Woehrlé F
    Vet Parasitol; 2006 Jan; 135(2):137-46. PubMed ID: 16242844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and parasitological evaluation of dogs naturally infected by Leishmania (Leishmania) chagasi submitted to treatment with meglumine antimoniate.
    Ikeda-Garcia FA; Lopes RS; Marques FJ; de Lima VM; Morinishi CK; Bonello FL; Zanette MF; Perri SH; Feitosa MM
    Vet Parasitol; 2007 Feb; 143(3-4):254-9. PubMed ID: 16996214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Efficacy of a Mixed Formulation of Conventional and PEGylated Liposomes Containing Meglumine Antimoniate, Combined with Allopurinol, in Dogs Naturally Infected with Leishmania infantum.
    Dos Santos CCP; Ramos GS; De Paula RC; Faria KF; Moreira POL; Pereira RA; Melo MN; Tafuri WL; Demicheli C; Ribeiro RR; Azevedo EG; Do Monte-Neto R; Da Silva SM; Frézard F
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32284386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and serological follow-up in dogs with visceral leishmaniosis treated with allopurinol and sodium stibogluconate.
    Pasa S; Toz SO; Voyvoda H; Ozbel Y
    Vet Parasitol; 2005 Mar; 128(3-4):243-9. PubMed ID: 15740861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First report of the use of meglumine antimoniate for treatment of canine leishmaniasis in a pregnant dog.
    Spada E; Proverbio D; Groppetti D; Perego R; Grieco V; Ferro E
    J Am Anim Hosp Assoc; 2011; 47(1):67-71. PubMed ID: 21164165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment.
    Solano-Gallego L; Riera C; Roura X; Iniesta L; Gallego M; Valladares JE; Fisa R; Castillejo S; Alberola J; Ferrer L; Arboix M; Portús M
    Vet Parasitol; 2001 Apr; 96(4):265-76. PubMed ID: 11267753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of renal and hepatic functions in dogs naturally infected by visceral leishmaniasis submitted to treatment with meglumine antimoniate.
    Ikeda-Garcia FA; Lopes RS; Ciarlini PC; Marques FJ; Lima VM; Perri SH; Feitosa MM
    Res Vet Sci; 2007 Aug; 83(1):105-8. PubMed ID: 17150234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of serum albumin/globulin ratio after antimonial therapy in canine leishmaniasis.
    Amusategui I; Sainz A; Tesouro MA
    Ann N Y Acad Sci; 1998 Jun; 849():447-9. PubMed ID: 9668510
    [No Abstract]   [Full Text] [Related]  

  • 17. Prospective evaluation of serum pancreatic lipase immunoreactivity and troponin I concentrations in Leishmania infantum-infected dogs treated with meglumine antimonate.
    Xenoulis PG; Saridomichelakis MN; Chatzis MK; Kasabalis D; Petanides T; Suchodolski JS; Steiner JM
    Vet Parasitol; 2014 Jul; 203(3-4):326-30. PubMed ID: 24813787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of different tissue sampling for PCR-based diagnosis and follow-up of canine visceral leishmaniosis.
    Manna L; Vitale F; Reale S; Caracappa S; Pavone LM; Morte RD; Cringoli G; Staiano N; Gravino AE
    Vet Parasitol; 2004 Nov; 125(3-4):251-62. PubMed ID: 15482882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canine leishmaniasis chemotherapy: dog's clinical condition and risk of Leishmania transmission.
    João A; Pereira MA; Cortes S; Santos-Gomes GM
    J Vet Med A Physiol Pathol Clin Med; 2006 Dec; 53(10):540-5. PubMed ID: 17105576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum concentrations of acute-phase proteins in dogs with leishmaniosis during short-term treatment.
    Martínez-Subiela S; Bernal LJ; Cerón JJ
    Am J Vet Res; 2003 Aug; 64(8):1021-6. PubMed ID: 12926596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.